PENTERO 900: Elevating Excellence in Microsurgery to a New Level

Carl Zeiss Meditec proudly presents the next generation surgical microscope.

JENA, Germany – April 11th 2011. Carl Zeiss Meditec today introduces the all-new PENTERO® 900 surgical microscope system at the 79th AANS (Annual Meeting of the American Association of Neurological Surgeons) in Denver, Colorado. Based on the breakthrough OPMI® Pentero surgical visualization platform launched in 2004, PENTERO 900 offers innovative new features and customer benefits such as:

PENTERO 900 combines unique design concepts and new functionalities in a proven-fully integrated platform.

HD quality for education, presentations and patient documentation
PENTERO 900 offers razor-sharp images in HD quality – camera, recorder, editor and touchscreen monitor are all contained in a fully integrated HD chain. The playback of high resolution HD images and videos is beneficial for surgeons during live demonstrations, resident education, presentations and patient documentation.

New fields of application for fluorescence
The YELLOW 560 option visualizes fluorescence in the wavelength range from 540 to 690nm supporting new fields of application and research. YELLOW 560 effectively complements the existing ZEISS fluorescence portfolio including BLUE 400, INFRARED 800 and FLOW 800 modules, paving the way for future application developments.

Comfortable working positions with new foldable binocular tube
The Foldable Tube f170/f260 combines brilliant apochromatic optics and a revolutionary design for maximum visualization flexibility, magnification potential and positioning ergonomics. It offers surgeons an unprecedented range of comfortable working positions, even at extreme surgical approach angles. The PROMAGTM function instantly yields a 50% gain in magnification for delicate and detailed procedures.

“When we introduced OPMI Pentero to the market in 2004, we set new, pioneering standards in the user-oriented enhancement of surgical microscope design. With the new features on PENTERO 900, we are propelling the microsurgical platform into a new dimension,” said Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec.

Brief profile
Carl Zeiss Meditec AG (ISIN: DE0005313704) is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented solutions which enable doctors to improve the quality of life of their patients. It offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. In the field of microsurgery the company provides innovative visualization solutions. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising future-oriented technologies such as intraoperative radiotherapy. The Company’s around 2,200 employees generated revenues of about EUR 676 million in fiscal year 2009/10 (ended Sept. 30).

Carl Zeiss Meditec is headquartered in Jena, Germany. In addition to other subsidiaries in Germany, the company is represented by over 50 percent of its employees at sites in the USA, Japan, Spain and France. 35 percent of Carl Zeiss Meditec shares are in free float. The remaining 65% are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industry. Carl Zeiss offers innovative solutions for the future-oriented markets of Medical and Research Solutions, Industrial Solutions, Eye Care and Lifestyle Products. During fiscal year 2009/109 the group of companies generated revenues of around EUR 2.98 billion. From fiscal year 2010/11, eyeglass lens manufacturer Carl Zeiss Vision will be integrated as an autonomous business group (revenues of EUR 880 million in fiscal year 2009/10). The Carl Zeiss Group now has approximately 24,000 employees, including more than 10,000 in Germany. Carl Zeiss AG, Oberkochen, is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).

For more information, please go to

www.meditec.zeiss.de